- 1/6 Our paper today – www.nature.com/articles/s41... work from Kenya - shows protective antibodies against falciparum malaria sporozoites work against sporozoites injected into the skin, not against sporozoites injected into veins. Why does this matter?
- 2/6 Vaccines R21 and RTS,S protect through antibodies against falciparum sporozoites, many millions of doses to be given across Africa, vaccine schedules needed in new populations. Schedules guided by antibody responses. How do antibody levels relate to protection?Jan 6, 2026 14:00
- 3/6 Mosquitoes inject malaria sporozoites mostly into the skin, sometimes into blood vessels. In animal models sporozoites are more easily blocked in the skin compared with in blood vessels. Is this true in humans? We injected sporozoites into vaccinated volunteers.
- 4/6 All unvaccinated volunteers got malaria. None of the R21 vaccinated volunteers getting skin sporozoites got infected. All the R21 vaccinated volunteers getting intravenous sporozoites got infected.
- 5/6 This means if we want a hard and fast antibody level to predict protection, we need to look for different levels for skin sporozoites versus intravenous sporozoites.
- 6/6 Work led by @melissakapulu.bsky.social funded by @wellcometrust.bsky.social and @globalhealthedctp3.bsky.social in @kemriwellcome.bsky.social with sporozoites from Sanaria (enabling challenge studies across Africa). Pleasure to work with you all!